Skip to main content
. 2023 Nov 9;55(11):2320–2331. doi: 10.1038/s12276-023-01118-6

Fig. 4. Differential regulation of NA-sensing signaling pathways in therapy.

Fig. 4

a NA-sensing promotes the antitumor therapeutic efficacy of immune checkpoint inhibitors by inducing dendritic cell (DC) maturation and tumor-specific T-cell responses and promotes the differentiation of macrophages into M1 proinflammatory macrophages. b In the metastatic stage of cancer, NA-sensing-induced inflammatory cytokines exhibit cancer-promoting effects. c Model of antigen-specific immunity mediated by nonviral gene therapies and the negative regulatory effects of NA-sensing on therapeutic transgenes.